Concise Review

Laying the Groundwork for a First-In-Human Study of an Induced Pluripotent Stem Cell-Based Intervention for Spinal Cord Injury

Osahiko Tsuji, Keiko Sugai, Ryo Yamaguchi, Syoichi Tashiro, Narihito Nagoshi, Jun Kohyama, Tsuyoshi Iida, Toshiki Ohkubo, Go Itakura, Miho Isoda, Munehisa Shinozaki, Kanehiro Fujiyoshi, Yonehiro Kanemura, Shinya Yamanaka, Masaya Nakamura, Hideyuki Okano

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

There have been numerous attempts to develop stem cell transplantation approaches to promote the regeneration of spinal cord injury (SCI). Our multicenter team is currently planning to launch a first-in-human clinical study of an induced pluripotent stem cell (iPSC)-based cell transplant intervention for subacute SCI. This trial was conducted as class I regenerative medicine protocol as provided for under Japan's Act on the Safety of Regenerative Medicine, using neural stem/progenitor cells derived from a clinical-grade, integration-free human “iPSC stock” generated by the Kyoto University Center for iPS Cell Research and Application. In the present article, we describe how we are preparing to initiate this clinical study, including addressing the issues of safety and tumorigenesis as well as practical problems that must be overcome to enable the development of therapeutic interventions for patients with chronic SCI. Stem Cells 2018.

Original languageEnglish
JournalStem Cells
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Induced Pluripotent Stem Cells
Spinal Cord Injuries
Regenerative Medicine
Stem Cells
Safety
Neural Stem Cells
Stem Cell Transplantation
Regeneration
Japan
Carcinogenesis
Transplants
Research
Clinical Studies
Therapeutics

Keywords

  • Cell transplantation
  • Clinical trials
  • Induced pluripotent stem cells
  • Spinal cord injury

ASJC Scopus subject areas

  • Molecular Medicine
  • Developmental Biology
  • Cell Biology

Cite this

Concise Review : Laying the Groundwork for a First-In-Human Study of an Induced Pluripotent Stem Cell-Based Intervention for Spinal Cord Injury. / Tsuji, Osahiko; Sugai, Keiko; Yamaguchi, Ryo; Tashiro, Syoichi; Nagoshi, Narihito; Kohyama, Jun; Iida, Tsuyoshi; Ohkubo, Toshiki; Itakura, Go; Isoda, Miho; Shinozaki, Munehisa; Fujiyoshi, Kanehiro; Kanemura, Yonehiro; Yamanaka, Shinya; Nakamura, Masaya; Okano, Hideyuki.

In: Stem Cells, 01.01.2018.

Research output: Contribution to journalArticle

Tsuji, Osahiko ; Sugai, Keiko ; Yamaguchi, Ryo ; Tashiro, Syoichi ; Nagoshi, Narihito ; Kohyama, Jun ; Iida, Tsuyoshi ; Ohkubo, Toshiki ; Itakura, Go ; Isoda, Miho ; Shinozaki, Munehisa ; Fujiyoshi, Kanehiro ; Kanemura, Yonehiro ; Yamanaka, Shinya ; Nakamura, Masaya ; Okano, Hideyuki. / Concise Review : Laying the Groundwork for a First-In-Human Study of an Induced Pluripotent Stem Cell-Based Intervention for Spinal Cord Injury. In: Stem Cells. 2018.
@article{43328ec679c34b15ad324792107d8b97,
title = "Concise Review: Laying the Groundwork for a First-In-Human Study of an Induced Pluripotent Stem Cell-Based Intervention for Spinal Cord Injury",
abstract = "There have been numerous attempts to develop stem cell transplantation approaches to promote the regeneration of spinal cord injury (SCI). Our multicenter team is currently planning to launch a first-in-human clinical study of an induced pluripotent stem cell (iPSC)-based cell transplant intervention for subacute SCI. This trial was conducted as class I regenerative medicine protocol as provided for under Japan's Act on the Safety of Regenerative Medicine, using neural stem/progenitor cells derived from a clinical-grade, integration-free human “iPSC stock” generated by the Kyoto University Center for iPS Cell Research and Application. In the present article, we describe how we are preparing to initiate this clinical study, including addressing the issues of safety and tumorigenesis as well as practical problems that must be overcome to enable the development of therapeutic interventions for patients with chronic SCI. Stem Cells 2018.",
keywords = "Cell transplantation, Clinical trials, Induced pluripotent stem cells, Spinal cord injury",
author = "Osahiko Tsuji and Keiko Sugai and Ryo Yamaguchi and Syoichi Tashiro and Narihito Nagoshi and Jun Kohyama and Tsuyoshi Iida and Toshiki Ohkubo and Go Itakura and Miho Isoda and Munehisa Shinozaki and Kanehiro Fujiyoshi and Yonehiro Kanemura and Shinya Yamanaka and Masaya Nakamura and Hideyuki Okano",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/stem.2926",
language = "English",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Concise Review

T2 - Laying the Groundwork for a First-In-Human Study of an Induced Pluripotent Stem Cell-Based Intervention for Spinal Cord Injury

AU - Tsuji, Osahiko

AU - Sugai, Keiko

AU - Yamaguchi, Ryo

AU - Tashiro, Syoichi

AU - Nagoshi, Narihito

AU - Kohyama, Jun

AU - Iida, Tsuyoshi

AU - Ohkubo, Toshiki

AU - Itakura, Go

AU - Isoda, Miho

AU - Shinozaki, Munehisa

AU - Fujiyoshi, Kanehiro

AU - Kanemura, Yonehiro

AU - Yamanaka, Shinya

AU - Nakamura, Masaya

AU - Okano, Hideyuki

PY - 2018/1/1

Y1 - 2018/1/1

N2 - There have been numerous attempts to develop stem cell transplantation approaches to promote the regeneration of spinal cord injury (SCI). Our multicenter team is currently planning to launch a first-in-human clinical study of an induced pluripotent stem cell (iPSC)-based cell transplant intervention for subacute SCI. This trial was conducted as class I regenerative medicine protocol as provided for under Japan's Act on the Safety of Regenerative Medicine, using neural stem/progenitor cells derived from a clinical-grade, integration-free human “iPSC stock” generated by the Kyoto University Center for iPS Cell Research and Application. In the present article, we describe how we are preparing to initiate this clinical study, including addressing the issues of safety and tumorigenesis as well as practical problems that must be overcome to enable the development of therapeutic interventions for patients with chronic SCI. Stem Cells 2018.

AB - There have been numerous attempts to develop stem cell transplantation approaches to promote the regeneration of spinal cord injury (SCI). Our multicenter team is currently planning to launch a first-in-human clinical study of an induced pluripotent stem cell (iPSC)-based cell transplant intervention for subacute SCI. This trial was conducted as class I regenerative medicine protocol as provided for under Japan's Act on the Safety of Regenerative Medicine, using neural stem/progenitor cells derived from a clinical-grade, integration-free human “iPSC stock” generated by the Kyoto University Center for iPS Cell Research and Application. In the present article, we describe how we are preparing to initiate this clinical study, including addressing the issues of safety and tumorigenesis as well as practical problems that must be overcome to enable the development of therapeutic interventions for patients with chronic SCI. Stem Cells 2018.

KW - Cell transplantation

KW - Clinical trials

KW - Induced pluripotent stem cells

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=85056420836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056420836&partnerID=8YFLogxK

U2 - 10.1002/stem.2926

DO - 10.1002/stem.2926

M3 - Article

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

ER -